# Xperi Inc.: overview XPER · NYSE · CIK 1788999 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/xper.md) · [Financials](/companies/xper/financials.md) · [Filings](/companies/xper/filings.md) · [Insiders](/companies/xper/insiders.md) Latest reported revenue: [$114.5m](/filings/0001788999-26-000018.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001788999-26-000018). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [133](/filings/0001193125-25-269600.md) | [122 d](/filings/0001193125-26-076849.md) | [114](/filings/0001788999-26-000013.md) | [106](/filings/0001788999-26-000018.md) | [112](/filings/0001193125-25-269600.md) | [117 d](/filings/0001193125-26-076849.md) | [114](/filings/0001788999-26-000013.md) | [114](/filings/0001788999-26-000018.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(14.0%)](/filings/0001193125-25-269600.md) | [(11.7%) d](/filings/0001193125-26-076849.md) | [(14.4%)](/filings/0001788999-26-000013.md) | [(10.5%)](/filings/0001788999-26-000018.md) | [(1.2%)](/filings/0001193125-25-269600.md) | [(12.7%) d](/filings/0001193125-26-076849.md) | [1.9%](/filings/0001788999-26-000013.md) | [2.5%](/filings/0001788999-26-000018.md) | | Net margin | % | [(12.6%)](/filings/0001193125-25-269600.md) | [37.8% d](/filings/0001193125-26-076849.md) | [(16.1%)](/filings/0000950170-25-067036.md) | [(14.0%)](/filings/0001788999-26-000018.md) | [(5.5%)](/filings/0001193125-25-269600.md) | [(14.7%) d](/filings/0001193125-26-076849.md) | [(6.9%)](/filings/0001788999-26-000013.md) | [(1.3%)](/filings/0001788999-26-000018.md) | | Diluted EPS | $ per share | [(0.37)](/filings/0001193125-25-269600.md) | not reported | [(0.41)](/filings/0001788999-26-000013.md) | [(0.32)](/filings/0001788999-26-000018.md) | [(0.13)](/filings/0001193125-25-269600.md) | not reported | [(0.17)](/filings/0001788999-26-000013.md) | [(0.03)](/filings/0001788999-26-000018.md) | | Free cash flow | $m | [(5.6) d](/filings/0001193125-25-269600.md) | [(0.5) d](/filings/0001193125-26-076849.md) | [(23.3)](/filings/0001788999-26-000013.md) | [9.5 d](/filings/0001788999-26-000018.md) | [6.7 d](/filings/0001193125-25-269600.md) | [1.2 d](/filings/0001193125-26-076849.md) | [(19.1)](/filings/0001788999-26-000013.md) | [14.1 d](/filings/0001788999-26-000018.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [486](/filings/0000950170-24-023915.md) | [502](/filings/0000950170-25-029159.md) | [521](/filings/0001193125-26-076849.md) | [494](/filings/0001193125-26-076849.md) | [448](/filings/0001193125-26-076849.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(33.3%)](/filings/0000950170-24-023915.md) | [(149.2%)](/filings/0000950170-25-029159.md) | [(24.9%)](/filings/0001193125-26-076849.md) | [(17.6%)](/filings/0001193125-26-076849.md) | [(9.8%)](/filings/0001193125-26-076849.md) | | Net margin | % | [(36.1%)](/filings/0000950170-24-023915.md) | [(150.8%)](/filings/0000950170-25-029159.md) | [(26.2%)](/filings/0001193125-26-076849.md) | [(2.8%)](/filings/0001193125-26-076849.md) | [(12.6%)](/filings/0001193125-26-076849.md) | | Diluted EPS | $ per share | [(4.18)](/filings/0000950170-24-023915.md) | [(18.02)](/filings/0000950170-25-029159.md) | [(3.18)](/filings/0001193125-26-076849.md) | [(0.31)](/filings/0001193125-26-076849.md) | [(1.23)](/filings/0001193125-26-076849.md) | | Free cash flow | $m | [(32.3)](/filings/0000950170-24-023915.md) | [(41.5)](/filings/0000950170-25-029159.md) | [(6.8)](/filings/0001193125-26-076849.md) | [(60.4)](/filings/0001193125-26-076849.md) | [(5.9)](/filings/0001193125-26-076849.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/xper/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Rubric Capital Management LP](/funds/1687509.md) | 2026-06-30 | $34.1m | 4,143,744 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $33.2m | 4,040,053 | | Added +77,290 | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $25.5m | 3,092,416 | | Added +613,428 | | [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $23.6m | 2,864,605 | | Added +233,053 | | [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $20.4m | 2,483,786 | | Added +255,082 | | [Clearline Capital LP](/funds/1600136.md) | 2026-06-30 | $20.4m | 2,475,135 | | Reduced −477,860 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $16.8m | 2,045,746 | | Added +95,087 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $16.8m | 2,035,886 | | Added +91,875 | | [Caption Management, LLC](/funds/1706766.md) | 2026-06-30 | $16.6m | 2,021,500 | Put | Added +680,900 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $10.4m | 1,269,590 | | Added +146,089 | ## Recent filings [All 242 filings](/companies/xper/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-07 | 10:00 ET | [8-K](/filings/0001788999-26-000020.md) | 7.01 Regulation FD disclosure | 0001788999-26-000020 | | 2026-08-06 | 20:16 ET | [10-Q](/filings/0001788999-26-000018.md) | Quarterly report, period 2026-06-30 | 0001788999-26-000018 | | 2026-08-05 | 20:09 ET | [8-K](/filings/0001788999-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001788999-26-000015 | | 2026-05-07 | 20:17 ET | [10-Q](/filings/0001788999-26-000013.md) | Quarterly report, period 2026-03-31 | 0001788999-26-000013 | | 2026-05-06 | 20:18 ET | [8-K](/filings/0001788999-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001788999-26-000010 | | 2026-04-20 | 20:30 ET | [8-K](/filings/0001788999-26-000008.md) | 5.07 Shareholder vote results | 0001788999-26-000008 | | 2026-03-04 | 21:10 ET | [DEF 14A](/filings/0001788999-26-000004.md) | Proxy statement, period 2026-03-04 | 0001788999-26-000004 | | 2026-02-26 | 21:27 ET | [10-K](/filings/0001193125-26-076849.md) | Annual report, period 2025-12-31 | 0001193125-26-076849 | | 2026-02-25 | 21:22 ET | [8-K](/filings/0001193125-26-071698.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071698 | | 2025-11-06 | 21:18 ET | [10-Q](/filings/0001193125-25-269600.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269600 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-076849.md), filed Feb 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/fadf3fdf-2e1b-4c26-b1d4-913421a1bfe2) ## About the filer - CIK: 1788999 - Tickers: XPER - Exchange: NYSE - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.